Neuroprotective actions of estradiol revisited

Trends Endocrinol Metab. 2011 Dec;22(12):467-73. doi: 10.1016/j.tem.2011.08.002. Epub 2011 Aug 31.

Abstract

Results from animal experiments showing that estradiol is neuroprotective were challenged 10 years ago by findings indicating an increased risk of dementia and stroke in women over 65 years of age taking conjugated equine estrogens. Our understanding of the complex signaling of estradiol in neural cells has recently clarified the causes of this discrepancy. New data indicate that estradiol may lose its neuroprotective activity or even increase neural damage, a situation that depends on the duration of ovarian hormone deprivation and on age-associated modifications in the levels of other molecules that modulate estradiol action. These studies highlight the complex neuroprotective mechanisms of estradiol and suggest a window of opportunity during which effective hormonal therapy could promote brain function and cognition.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aging / metabolism
  • Animals
  • Estradiol / adverse effects
  • Estradiol / metabolism
  • Estradiol / therapeutic use*
  • Estrogen Replacement Therapy / adverse effects
  • Female
  • Humans
  • Male
  • Neuroglia / drug effects
  • Neuroglia / metabolism
  • Neurons / drug effects*
  • Neurons / metabolism
  • Neuroprotective Agents / adverse effects
  • Neuroprotective Agents / therapeutic use*
  • Neurotoxicity Syndromes / epidemiology

Substances

  • Neuroprotective Agents
  • Estradiol